| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60cabc4ce80d392076a1eaf2a970a548 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2009-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_458706103c9540bb95c717c4534f7823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb9598c0559db426b059527d7762ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d91cb9f681986ebf2953d26009706f1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a84d0aa76230613e546bad06a0bffa4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5452dc6950f514693728931564f7d751 |
| publicationDate |
2011-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2270509-A1 |
| titleOfInvention |
Method for detection of liver cancer cell using anti-glypican-3 antibody |
| abstract |
The present invention relates to an in-vitro immunoassay method for detecting the presence of liver cancer cells in a subject. In the method of the present invention, antigen retrieval treatment based on heat-induced epitope retrieval method and antigen retrieval treatment based on protease-induced epitope retrieval method can be combined in the detection of glypican 3 antigen expression in liver cancer tissues to thereby detect the difference in the expression level or expression pattern of the glypican 3 antigen by immunohistochemical staining method. This enables samples, which has been determined by the conventional HIER method as highly expressing glypican 3, to be graded according to the expression level of glypican 3. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021216916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9409994-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113052228-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013181543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020086758-A1 |
| priorityDate |
2008-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |